Fiach C. O'Mahony Edinburgh Urological Cancer Group University of Edinburgh Biography Publications Institution JoVE Articles Fiach C. O'Mahony has not added a biography. If you are Fiach C. O'Mahony and would like to personalize this page please email our Author Liaison for assistance. Publications The Use of Automated Quantitative Analysis to Evaluate Epithelial-to-mesenchymal Transition Associated Proteins in Clear Cell Renal Cell Carcinoma PloS One. 2012 | Pubmed ID: 22363672 What Can Molecular Pathology Contribute to the Management of Renal Cell Carcinoma? Nature Reviews. Urology. May, 2011 | Pubmed ID: 21487387 Toxicological Profiling of Chemical and Environmental Samples Using Panels of Test Organisms and Optical Oxygen Respirometry Environmental Toxicology. Apr, 2009 | Pubmed ID: 18442072 Rapid High-throughput Assessment of Aerobic Bacteria in Complex Samples by Fluorescence-based Oxygen Respirometry Applied and Environmental Microbiology. Feb, 2006 | Pubmed ID: 16461677 Optical Oxygen Microrespirometry As a Platform for Environmental Toxicology and Animal Model Studies Environmental Science & Technology. Jul, 2005 | Pubmed ID: 16053104 The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicina
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicina